PHARMACOKINETICS AND BIOAVAILABILITY OF REDUCED AND OXIDIZED N-ACETYLCYSTEINE

被引：268

作者：

OLSSON, B

JOHANSSON, M

GABRIELSSON, J

BOLME, P

机构：

[1] UNIV UPPSALA, DEPT BIOPHARMACEUT & PHARMACOKINET, S-75105 UPPSALA, SWEDEN

[2] HUDDINGE HOSP, DEPT PAEDIAT, S-14186 HUDDINGE, SWEDEN

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 34卷 / 01期

关键词：

D O I：

10.1007/BF01061422

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：77 / 82

页数：6

共 22 条

[1]

BOMAN G, 1983, EUR J RESPIR DIS, V64, P405

[2]

BONANOMI L, 1980, EUR J RESPIR DIS, V61, P45

[3] PHARMACOKINETICS OF N-ACETYLCYSTEINE IN MAN [J].

BORGSTROM, L ;

KAGEDAL, B ;

PAULSEN, O .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (02) :217-222

[4]

COTGREAVE IA, 1986, B EUR PHYSIOPATH RES, V22, pS263

[5] METHODOLOGIES FOR THE ANALYSIS OF REDUCED AND OXIDIZED N-ACETYLCYSTEINE IN BIOLOGICAL-SYSTEMS [J].

COTGREAVE, IA ;

MOLDEUS, P .

BIOPHARMACEUTICS & DRUG DISPOSITION, 1987, 8 (04) :365-375

[6]

GIBALDI M, 1982, PHARMACOKINETICS

[7] CONTROLLED TRIAL OF INTERMITTENT ORAL ACETYLCYSTEINE IN LONG-TERM TREATMENT OF CHRONIC-BRONCHITIS [J].

GRASSI, C ;

MORANDINI, GC .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 9 (5-6) :393-396

[8]

HAKMAN M, 1986, INTRO MAXFIT USERS G

[9] DETERMINATION OF N-ACETYLCYSTEINE, INTACT AND OXIDIZED, IN PLASMA BY COLUMN LIQUID-CHROMATOGRAPHY AND POSTCOLUMN DERIVATIZATION [J].

JOHANSSON, M ;

WESTERLUND, D .

JOURNAL OF CHROMATOGRAPHY, 1987, 385 :343-356

[10]

KAGEDAL B, 1984, J CHROMATOGR, V311, P170, DOI 10.1016/S0378-4347(00)84705-2

← 1 2 3 →